Curcumin inhibits rift valley fever virus replication in human cells

Journal of Biological Chemistry

Volumn 287, Issue 40, 2012, Pages 33198-33214

  Narayanan, Aarthi ^a   Kehn Hall, Kylene ^a   Senina, Svetlana ^a   Lundberg, Lindsay ^a   Van Duyne, Rachel ^a,b   Guendel, Irene ^a   Das, Ravi ^a   Baer, Alan ^a   Bethel, Laura ^e   Turell, Michael ^c   Hartman, Amy Lynn ^e   Das, Bhaskar ^d,f   Bailey, Charles ^a   Kashanchi, Fatah ^a  

^a GEORGE MASON UNIVERSITY   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNITED STATES ARMY MEDICAL RESEARCH INSTITUTE OF INFECTIOUS DISEASES   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE; CURCUMIN; DATA POINTS; EXTRACELLULAR; FEVER VIRUS; HUMAN CELLS; INFECTED CELLS; INFECTIOUS VIRUS; KINASE ACTIVITY; LOW MOLECULAR WEIGHT; PROTEIN INTERACTION; RIFT VALLEY; THERAPEUTIC TARGETS; VIRAL LIFE CYCLE; VIRAL PROTEINS; VIRAL REPLICATION;

AMINO ACIDS; CYTOLOGY; ENZYMES; PHOSPHORYLATION; PROTEINS; VIRUSES;

CELLS;

CURCUMIN; I KAPPA B ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE BETA 2; NONSTRUCTURAL PROTEIN 1; SYNAPTOTAGMIN I; TRANSCRIPTION FACTOR RELA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CYCLE PROGRESSION; CELL VIABILITY; CONTROLLED STUDY; DOWN REGULATION; DRUG ACTIVITY; DRUG EFFICACY; DRUG PROTEIN BINDING; ENZYME ACTIVITY; ENZYME INHIBITION; FLOW CYTOMETRY; GEL PERMEATION CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIFE CYCLE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RIFT VALLEY FEVER; RIFT VALLEY FEVER BUNYAVIRUS; SIGNAL TRANSDUCTION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIVIRAL AGENTS; CELL LINE; CELL LINE, TUMOR; CURCUMIN; DOWN-REGULATION; ENZYME INHIBITORS; GENE EXPRESSION REGULATION, VIRAL; HUMANS; I-KAPPA B KINASE; MICE; MICE, TRANSGENIC; NF-KAPPA B; RIFT VALLEY FEVER; RIFT VALLEY FEVER VIRUS; TRANSCRIPTION, GENETIC; VIRUS REPLICATION;

ANIMALIA; ARBOVIRUS; RIFT VALLEY FEVER VIRUS;

EID: 84866954267     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.356535     Document Type: Article

References (63)

1. Flick, R., and Bouloy, M. (2005) Rift Valley fever virus. Curr. Mol. Med. 5, 827-834 (Pubitemid 43009521)
2. LaBeaud, A. D., Kazura, J. W., and King, C. H. (2010) Advances in Rift Valley fever research: insights for disease prevention. Curr. Opin. Infect. Dis. 23, 403-408
3. Ikegami, T., and Makino, S. (2009) Rift valley fever vaccines. Vaccine 27, Suppl. 4, D69-D72
4. Bouloy, M., and Flick, R. (2009) Reverse genetics technology for Rift Valley fever virus: current and future applications for the development of therapeutics and vaccines. Antiviral Res. 84, 101-118
5. Won, S., Ikegami, T., Peters, C. J., and Makino, S. (2007) NSm protein of Rift Valley fever virus suppresses virus-induced apoptosis. J. Virol. 81, 13335-13345 (Pubitemid 350247830)
6. Won, S., Ikegami, T., Peters, C. J., and Makino, S. (2006) NSm and 78-kilodalton proteins of Rift Valley fever virus are nonessential for viral replication in cell culture. J. Virol. 80, 8274-8278 (Pubitemid 44182329)
7. Billecocq, A., Spiegel, M., Vialat, P., Kohl, A., Weber, F., Bouloy, M., and Haller, O. (2004) NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription. J. Virol. 78, 9798-9806 (Pubitemid 39187098)
8. Bouloy, M., Janzen, C., Vialat, P., Khun, H., Pavlovic, J., Huerre, M., and Haller, O. (2001) Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs. J. Virol. 75, 1371-1377 (Pubitemid 32094695)
9. Dasgupta, A. (2004) Targeting TFIIH to inhibit host cell transcription by Rift Valley fever virus. Mol. Cell 13, 456-458
10. Habjan, M., Pichlmair, A., Elliott, R. M., Overby, A. K., Glatter, T., Gstaiger, M., Superti-Furga, G., Unger, H., and Weber, F. (2009) NSs protein of Rift Valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase. J. Virol. 83, 4365-4375
11. Ikegami, T., Narayanan, K., Won, S., Kamitani, W., Peters, C. J., and Makino, S. (2009) Rift Valley fever virus NSs protein promotes post-transcriptional down-regulation of protein kinase PKR and inhibits eIF2αphosphorylation. PLoS Pathog. 5, e1000287
12. Ikegami, T., Narayanan, K., Won, S., Kamitani, W., Peters, C. J., and Makino, S. (2009) Dual functions of Rift Valley fever virus NSs protein: inhibition of host mRNA transcription and post-transcriptional downregulation of protein kinase PKR. Ann. N.Y. Acad. Sci. 1171, Suppl. 1, E75-E85
13. Ikegami, T., Peters, C. J., and Makino, S. (2005) Rift Valley fever virus nonstructural protein NSs promotes viral RNA replication and transcription in a minigenome system. J. Virol. 79, 5606-5615 (Pubitemid 40548229)
14. Kalveram, B., Lihoradova, O., and Ikegami, T. (2011) NSs protein of Rift Valley fever virus promotes posttranslational down-regulation of the TFIIH subunit p62. J. Virol. 85, 6234-6243
15. Le May, N., Dubaele, S., Proietti De Santis, L., Billecocq, A., Bouloy, M., and Egly, J. M. (2004) TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. Cell 116, 541-550 (Pubitemid 38264431)
16. Le May, N., Mansuroglu, Z., Leger, P., Josse, T., Blot, G., Billecocq, A., Flick, R., Jacob, Y., Bonnefoy, E., and Bouloy, M. (2008) A SAP30 complex inhibits IFN-β expression in Rift Valley fever virus-infected cells. PLoS Pathog. 4, e13
17. Narayanan, A., Popova, T., Turell, M., Kidd, J., Chertow, J., Popov, S. G., Bailey, C., Kashanchi, F., and Kehn-Hall, K. (2011) Alteration in superoxide dismutase 1 causes oxidative stress and p38 MAPK activation following RVFV infection. PLoS One 6, e20354
18. Popova, T. G., Turell, M. J., Espina, V., Kehn-Hall, K., Kidd, J., Narayanan, A., Liotta, L., Petricoin, E. F., 3rd, Kashanchi, F., Bailey, C., and Popov, S. G. (2010) Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift Valley fever virus in human small airway epithelial cells. PLoS One 5, e13805
19. Ahmed, K. M., and Li, J. J. (2007) ATM-NF-κB connection as a target for tumor radiosensitization. Curr. Cancer Drug Targets 7, 335-342 (Pubitemid 46849238)
20. Dent, P., Yacoub, A., Contessa, J., Caron, R., Amorino, G., Valerie, K., Hagan, M. P., Grant, S., and Schmidt-Ullrich, R. (2003) Stress and radiation-induced activation of multiple intracellular signaling pathways. Radiat Res. 159, 283-300 (Pubitemid 36314943)
21. Haddad, J. J., Saadé, N. E., and Safieh-Garabedian, B. (2002) Redox regulation of TNF-α biosynthesis: augmentation by irreversible inhibition of γ-glutamylcysteine synthetase and the involvement of an IκB-α/NF-κB-independent pathway in alveolar epithelial cells. Cell. Signal. 14, 211-218 (Pubitemid 34102450)
22. Pan, D., Pan, L. Z., Hill, R., Marcato, P., Shmulevitz, M., Vassilev, L. T., and Lee, P. W. (2011) Stabilisation of p53 enhances reovirus-induced apoptosis and virus spread through p53-dependent NF-κB activation. Br. J. Cancer 105, 1012-1022
23. Pise-Masison, C. A., Mahieux, R., Radonovich, M., Jiang, H., Duvall, J., Guillerm, C., and Brady, J. N. (2000) Insights into the molecular mechanism of p53 inhibition by HTLV type 1 Tax. AIDS Res. Hum. Retroviruses 16, 1669-1675
24. Rahman, I., Marwick, J., and Kirkham, P. (2004) Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-κB and pro-inflammatory gene expression. Biochem. Pharmacol. 68, 1255-1267 (Pubitemid 39094292)
25. Oeckinghaus, A., Hayden, M. S., and Ghosh, S. (2011) Cross-talk in NF-κB signaling pathways. Nat. Immunol. 12, 695-708
26. Filone, C. M., Hanna, S. L., Caino, M. C., Bambina, S., Doms, R. W., and Cherry, S. (2010) Rift Valley fever virus infection of human cells and insect hosts is promoted by protein kinase Cε. PLoS One 5, e15483
27. Panchal, R. G., Reid, S. P., Tran, J. P., Bergeron, A. A., Wells, J., Kota, K. P., Aman, J., and Bavari, S. (2012) Identification of an antioxidant small-molecule with broad-spectrum antiviral activity. Antiviral Res. 93, 23-29
28. Ikegami, T., Won, S., Peters, C. J., and Makino, S. (2006) Rescue of infectious Rift Valley fever virus entirely from cDNA, analysis of virus lacking the NSs gene, and expression of a foreign gene. J. Virol. 80, 2933-2940 (Pubitemid 43346388)
29. Drosten, C., S., Schilling, S., Asper, M., Panning, M., Schmitz, H., and, S. (2002) Rapid detection and quantification of RNA of Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus, Rift Valley fever virus, dengue virus, and yellow fever virus by real-time reverse transcription-PCR. J. Clin. Microbiol. 40, 2323-2330
30. Agbottah, E., Yeh, W. I., Berro, R., Klase, Z., Pedati, C., Kehn-Hall, K., Wu, W., and Kashanchi, F. (2008) Two specific drugs, BMS-345541 and purvalanol A, induce apoptosis of HTLV-1-infected cells through inhibition of the NF-κB and cell cycle pathways. AIDS Res. Ther. 5, 12
31. Yoboua, F., Martel, A., Duval, A., Mukawera, E., and Grandvaux, N. (2010) Respiratory syncytial virus-mediated NF-κB p65 phosphorylation at serine 536 is dependent on RIG-I, TRAF6, and IKKβ. J. Virol. 84, 7267-7277
32. Douillette, A., Bibeau-Poirier, A., Gravel, S. P., J. F., V., Moreau, P., and Servant, M. J. (2006) The proinflammatory actions of angiotensin II are dependent on p65 phosphorylation by the IκB kinase complex. J. Biol. Chem. 281, 13275-13284 (Pubitemid 43855239)
33. Sripadi, P., Shrestha, B., Easley, R. L., Carpio, L., Kehn-Hall, K., Chevalier, S., Mahieux, R., Kashanchi, F., and Vertes, A. (2010) Direct detection of diverse metabolic changes in virally transformed and Tax-expressing cells by mass spectrometry. PLoS One 5, e12590
34. Sgarbanti, M., Arguello, M., tenOever, B. R., Battistini, A., Lin, R., and Hiscott, J. (2004) A requirement for NF-κB induction in the production of replication-competent HHV-8 virions. Oncogene 23, 5770-5780 (Pubitemid 39093022)
35. Sun, Q., Matta, H., Lu, G., and Chaudhary, P. M. (2006) Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-κB activation. Oncogene 25, 2717-2726
36. Caselli, E., Fiorentini, S., Amici, C., Di Luca, D., Caruso, A., and Santoro, M. G. (2007) Human herpesvirus 8 acute infection of endothelial cells induces monocyte chemoattractant protein 1-dependent capillary-like structure formation: role of the IKK/NF-κB pathway. Blood 109, 2718-2726 (Pubitemid 46482063)
37. Milacic, V., Banerjee, S., Landis-Piwowar, K. R., Sarkar, F. H., Majumdar, A. P., and Dou, Q. P. (2008) Curcumin inhibits the proteasome activity in human colon cancer cells in vitro and in vivo. Cancer Res. 68, 7283-7292
38. Fernandez-Garcia, M. D., Meertens, L., Bonazzi, M., Cossart, P., Arenzana-Seisdedos, F., and Amara, A. (2011) Appraising the roles of CBLL1 and the ubiquitin/proteasome system for flavivirus entry and replication. J. Virol. 85, 2980-2989
39. Wyke, S. M., Russell, S. T., and Tisdale, M. J. (2004) Induction of proteasome expression in skeletal muscle is attenuated by inhibitors of NF-κB activation. Br. J. Cancer 91, 1742-1750 (Pubitemid 39546149)
40. Smith, H. J., and Tisdale, M. J. (2003) Signal transduction pathways involved in proteolysis-inducing factor induced proteasome expression in murine myotubes. Br. J. Cancer 89, 1783-1788 (Pubitemid 37464154)
41. Pasquini, L. A., Paez, P. M., Moreno, M. A., Pasquini, J. M., and Soto, E. F. (2003) Inhibition of the proteasome by lactacystin enhances oligodendroglial cell differentiation. J. Neurosci. 23, 4635-4644 (Pubitemid 36712190)
42. Shakibaei, M., Csaki, C., Nebrich, S., and Mobasheri, A. (2008) Resveratrol suppresses interleukin-1β-induced inflammatory signaling and apoptosis in human articular chondrocytes: potential for use as a novel nutraceutical for the treatment of osteoarthritis. Biochem. Pharmacol. 76, 1426-1439
43. Kazi, A., Daniel, K. G., Smith, D. M., Kumar, N. B., and Dou, Q. P. (2003) Inhibition of the proteasome activity, a novel mechanism associated with the tumor cell apoptosis-inducing ability of genistein. Biochem. Pharmacol. 66, 965-976 (Pubitemid 37083593)
44. Baer, A., Austin, D., Narayanan, A., Popova, T., Kainulainen, M., Bailey, C., Kashanchi, F., Weber, F., and Kehn-Hall, K. (2012) Induction of DNA damage signaling upon Rift Valley fever virus infection results in cell cycle arrest and increased viral replication. J. Biol. Chem. 287, 7399-7410
45. Lorenzo, G., Martín-Folgar, R., Hevia, E., Boshra, H., and Brun, A. (2010) Protection against lethal Rift Valley fever virus (RVFV) infection in transgenic IFNAR(-/-) mice induced by differentDNAvaccination regimens. Vaccine 28, 2937-2944
46. Viatour, P., Merville, M. P., Bours, V., and Chariot, A. (2005) Phosphorylation of NF-κB and IκB proteins: implications in cancer and inflammation. Trends Biochem. Sci. 30, 43-52 (Pubitemid 40093740)
47. Häcker, H., and Karin, M. (2006) Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006, re13
48. O'Mahony, A., Lin, X., Geleziunas, R., and Greene, W. C. (2000) Activation of the heterodimeric IκB kinase α (IKKα)-IKKβ complex is directional: IKKα regulates IKKβ under both basal and stimulated conditions. Mol. Cell. Biol. 20, 1170-1178 (Pubitemid 30069237)
49. Dong, X., and Feng, P. (2011) Murine γ herpesvirus 68 hijacks MAVS and IKKβ to abrogate NFκB activation and antiviral cytokine production. PLoS Pathog. 7, e1002336
50. Benfield, C. T., Mansur, D. S., McCoy, L. E., Ferguson, B. J., Bahar, M. W., Oldring, A. P., Grimes, J. M., Stuart, D. I., Graham, S. C., and Smith, G. L. (2011) Mapping the IκB kinase beta (IKKβ)-binding interface of the B14 protein, a vaccinia virus inhibitor of IKKβ-mediated activation of nuclear factor κB. J. Biol. Chem. 286, 20727-20735
51. Chen, R. A., Ryzhakov, G., Cooray, S., Randow, F., and Smith, G. L. (2008) Inhibition of IκB kinase by vaccinia virus virulence factor B14. PLoS Pathog. 4, e22
52. Zheng, Z., Li, H., Zhang, Z., Meng, J., Mao, D., Bai, B., Lu, B., Mao, P., Hu, Q., and Wang, H. (2011) Enterovirus 71 2C protein inhibits TNF-α-mediated activation of NF-κB by suppressing IκB kinase β phosphorylation. J. Immunol. 187, 2202-2212
53. Valentine, R., Dawson, C. W., Hu, C., Shah, K. M., Owen, T. J., Date, K. L., Maia, S. P., Shao, J., Arrand, J. R., Young, L. S., and O'Neil, J. D. (2010) Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-kappaB pathway in carcinoma cells by inhibiting IKK phosphorylation. Mol. Cancer 9, 1
54. Jin, H., Yan, Z., Ma, Y., Cao, Y., and He, B. (2011) A herpesvirus virulence factor inhibits dendritic cell maturation through protein phosphatase 1 and IκB kinase. J. Virol. 85, 3397-3407
55. Wang, J., Tan, J., Zhang, X., Guo, H., Zhang, Q., Guo, T., Geng, Y., and Qiao, W. (2010) BFV activates the NF-κB pathway through its transactivator (BTas) to enhance viral transcription. Virology 400, 215-223
56. Aggarwal, B. B., and Harikumar, K. B. (2009) Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune, and neoplastic diseases. Int. J. Biochem. Cell Biol. 41, 40-59
57. Zhou, H., Beevers, C. S., and Huang, S. (2011) The targets of curcumin. Curr. Drug Targets 12, 332-347
58. Wan, S. B., Yang, H., Zhou, Z., Cui, Q. C., Chen, D., Kanwar, J., Mohammad, I., Dou, Q. P., and Chan, T. H. (2010) Evaluation of curcumin acetates and amino acid conjugates as proteasome inhibitors. Int. J. Mol. Med. 26, 447-455
59. Dattani, J. J., Rajput, D. K., Moid, N., Highland, H. N., George, L. B., and Desai, K. R. (2010) Ameliorative effect of curcumin on hepatotoxicity induced by chloroquine phosphate. Environ. Toxicol. Pharmacol. 30, 103-109
60. Tu, C. T., Han, B., Yao, Q. Y., Zhang, Y. A., Liu, H. C., and Zhang, S. C. (2012) Curcumin attenuates concanavalin A-induced liver injury in mice by inhibition of Toll-like receptor (TLR) 2, TLR4, and TLR9 expression. Int. Immunopharmacol. 12, 151-157
61. Tu, C. T., Han, B., Liu, H. C., and Zhang, S. C. (2011) Curcumin protects mice against concanavalin A-induced hepatitis by inhibiting intrahepatic intercellular adhesion molecule-1 (ICAM-1) and CXCL10 expression. Mol. Cell. Biochem. 358, 53-60
62. Yu, W. G., Xu, G., Ren, G. J., Xu, X., Yuan, H. Q., Qi, X. L., and Tian, K. L. (2011) Preventive action of curcumin in experimental acute pancreatitis in mouse. Indian J. Med. Res. 134, 717-724
63. Oh, S. W., Cha, J. Y., Jung, J. E., Chang, B. C., Kwon, H. J., Lee, B. R., and Kim, D. Y. (2011) Curcumin attenuates allergic airway inflammation and hyper-responsiveness in mice through NF-κB inhibition. J. Ethnopharmacol. 136, 414-421